Fisher M, Petrie MC, Ambery PD, Donaldson J, Ye J, McMurray JJ
Inset graphs show a close-up of the region from 190-220 nm
The use and popularity of incretin mimetics have recently accelerated due to compelling data demonstrating an improvement in major clinical endpoints for patients with T2D and a reduction in cardiovascular events
When the protease DPP-4 acts on these peptides to cleave the two N-terminal amino acids, these peptides are rendered inactive (Figure 7)
(Trump reversed that effort this year, barring Medicare and Medicaid from using them to treat the disease of obesity.) This plan to simplify payments and expand access would not make all drugs affordable in the United States, but increasing accessibility to GLP-1s can get us on the road to eliminating the significant problem of cardiometabolic disease and improving our health
DOI: 10.1016/j.appet.2021.105738